Back to: FDA Compounding Quality Center of Excellence Annual Conference 2025
Our volunteers were unable to capture the video for this session.
If you have a link to the recording, please let us know: [email protected]
About:
Learn how to apply the four critical U.S. Pharmacopeia (USP) General Chapters that define the microbiological testing landscape — [60], [61], [62], and [71] — in routine testing, understand how each chapter connects to risk management and patient safety and learn how to select a microbiology laboratory partner.
Presenter:
Abby Roth
Founder/Microbiologist
Pure Microbiology
Abby Roth, founder of Pure Microbiology, has supported the pharmaceutical, medical device, and compounding industries since 2004. An expert in EM and sterile compounding, she develops training curricula and industry guidance, and is currently serving on the CETA Board of Directors.